Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-02 Purchase | 2024-04-04 4:30 pm | Boundless Bio Inc. | BOLD | Burow Kristina Director 10% Owner | 200,000 | $16 | $3,200,000 | 1,181,766 (Indirect) | View |
| 2024-02-15 Purchase | 2024-02-20 5:37 pm | Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 3,200,000 | $6.25 | $20,000,000 | 15,456,594 (Indirect) | View |
| 2024-02-08 Purchase | 2024-02-12 5:43 pm | Sana Biotechnology Inc. | SANA | CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner | 1,818,181 | $5.5 | $9,999,996 | 22,747,272 (Indirect) | View |
| 2023-11-13 Purchase | 2023-11-15 6:55 pm | Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner | 35,010 | $11.77 | $412,140 | 4,144,827 (Indirect Direct) | View |
| 2023-11-08 Purchase | 2023-11-13 7:01 pm | Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner | 140,605 | $10.98 | $1,543,563 | 4,109,817 (Indirect Direct) | View |
| 2023-11-03 Purchase | 2023-11-07 7:00 pm | Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner | 95,694 | $11.49 | $1,099,945 | 3,969,212 (Indirect Direct) | View |
| 2023-09-28 Purchase | 2023-09-29 6:55 pm | Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner | 76,511 | $13.68 | $1,046,848 | 3,873,518 (Indirect Direct) | View |
| 2023-09-26 Purchase | 2023-09-27 8:19 pm | Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner | 58,504 | $11.97 | $700,464 | 3,797,007 (Indirect Direct) | View |
| 2023-09-22 Purchase | 2023-09-25 9:37 pm | Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner | 100,740 | $11.19 | $1,127,064 | 3,738,503 (Indirect Direct) | View |
| 2023-09-19 Purchase | 2023-09-20 06:23 am | Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner | 1,500,000 | $17 | $25,500,000 | 3,637,763 (Indirect Direct) | View |
| 2022-10-24 Purchase | 2022-10-26 8:01 pm | Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 800,000 | $17 | $13,600,000 | 6,128,297 (Indirect) | View |
| 2021-07-30 Purchase | 2021-08-03 9:06 pm | DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 1,600,000 | $10 | $16,000,000 | 4,500,000 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-02 Conversion | 2024-04-04 4:30 pm | N/A N/A | Boundless Bio Inc. | BOLD | Burow Kristina Director 10% Owner | 4,851,442 | $0 | 1,181,766 (Indirect) | View |
| 2024-03-27 Option Award | 2024-03-29 4:30 pm | N/A 2034-03-26 | Boundless Bio Inc. | BOLD | Burow Kristina Director 10% Owner | 26,438 | $0 | 26,438 (Direct) | View |
Ownership | 2024-03-27 8:11 pm | N/A N/A | Boundless Bio Inc. | BOLD | Burow Kristina Director 10% Owner | 0 | $0 | 2,494,095 (Indirect) | View |
| 2023-12-21 Other | 2023-12-26 5:36 pm | N/A N/A | Scholar Rock Holding Corp | SRRK | Burow Kristina Director | 297,245 | $0 | 2,648,295 (Indirect) | View |
| 2023-12-08 Other | 2023-12-12 7:52 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner | 1,893,651 | $0 | 34,275,819 (Indirect) | View |
| 2023-09-19 Conversion | 2023-09-20 06:23 am | N/A N/A | Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner | 17,438,324 | $0 | 3,637,763 (Direct) | View |
| 2023-09-14 Option Award | 2023-09-18 5:54 pm | N/A 2033-09-13 | Neumora Therapeutics Inc. | NMRA | Burow Kristina Director | 46,455 | $0 | 46,455 (Direct) | View |
Ownership | 2023-09-14 8:56 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner | 0 | $0 | 28,059,040 (Indirect) | View |
| 2023-07-28 Other | 2023-08-10 8:27 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 1,600,000 | $0 | 2,250,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 07:34 am | N/A 2033-06-21 | Scholar Rock Holding Corp | SRRK | Burow Kristina Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 4:13 pm | N/A 2033-06-07 | Gossamer Bio Inc. | GOSS | Burow Kristina Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 5:02 pm | N/A 2033-06-06 | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 16,532 | $0 | 5,485,582 (Direct) | View |
| 2022-10-24 Conversion | 2022-10-26 8:01 pm | N/A N/A | Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 41,344,576 | $0 | 6,128,297 (Indirect) | View |
Ownership | 2022-10-19 8:08 pm | N/A N/A | Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 11,456,594 (Indirect) | View |
| 2022-09-01 Option Award | 2022-09-02 4:06 pm | N/A 2032-09-01 | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 10,391 | $0 | 10,391 (Direct) | View |
| 2022-06-09 Option Award | 2022-07-15 5:21 pm | N/A 2032-06-08 | Gossamer Bio Inc. | GOSS | Burow Kristina Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-27 4:32 pm | N/A 2032-05-26 | Scholar Rock Holding Corp | SRRK | Burow Kristina Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2021-08-05 Other | 2021-08-09 8:31 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN Member of 10% owner group 10% Owner | 701,250 | $0 | 4,465,000 (Indirect) | View |
| 2021-07-30 Other | 2021-08-03 9:06 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 650,000 | $10 | 4,500,000 (Indirect) | View |
Ownership | 2021-07-27 9:58 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 5,166,250 (Indirect) | View |
| 2021-07-20 Conversion | 2021-07-20 8:53 pm | N/A N/A | Erasca Inc. | ERAS | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 18,794,443 | $0 | 5,527,777 (Indirect) | View |
Ownership | 2021-07-15 9:06 pm | N/A N/A | Erasca Inc. | ERAS | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 11,055,554 (Indirect) | View |
| 2021-06-30 Other | 2021-07-02 5:20 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 202,011 | $0 | 3,335,597 (Indirect) | View |
| 2021-06-25 Other | 2021-06-29 5:20 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 404,022 | $0 | 3,935,597 (Indirect) | View |
| 2021-06-24 Option Award | 2021-06-28 5:12 pm | N/A 2031-06-23 | Unity Biotechnology Inc. | UBX | Burow Kristina Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-06-21 Conversion | 2021-06-23 4:29 pm | N/A N/A | Verve Therapeutics Inc. | VERV | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 25,739,146 | $0 | 1,254,405 (Indirect) | View |
Ownership | 2021-06-16 7:35 pm | N/A N/A | Verve Therapeutics Inc. | VERV | ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners X LLC CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 2,508,809 (Indirect) | View |
| 2021-06-10 Option Award | 2021-06-14 07:55 am | N/A 2031-06-10 | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 6,877 | $0 | 6,877 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-10 9:01 pm | N/A 2031-06-08 | Gossamer Bio Inc. | GOSS | Burow Kristina Director | 23,500 | $0 | 23,500 (Direct) | View |
| 2021-05-27 Option Award | 2021-06-01 5:03 pm | N/A 2031-05-27 | Scholar Rock Holding Corp | SRRK | Burow Kristina Director | 7,800 | $0 | 7,800 (Direct) | View |
| 2021-05-24 Option Award | 2021-05-25 6:58 pm | N/A 2031-05-23 | Metacrine Inc. | MTCR | Burow Kristina Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2021-03-31 Other | 2021-04-02 3:21 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 202,011 | $0 | 3,929,564 (Indirect) | View |